GSK, Sanofi delay data on Covid-19 vaccine booster candidate until 2022
GlaxoSmithKline (GSK) and Sanofi said on Wednesday (December 15) they expect data from late-stage clinical trials of its booster dose of their Covid-19 vaccine candidate in...